SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-04-07 15:55
Tx date 2022-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$2,591
+366 vol
$7.08 each
Filed 2026-04-07 15:54
Tx date 2024-03-27 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+17,103 vol
Older filings
Filed 2024-04-02 18:36
Tx date 2024-03-27 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+17,103 vol
Filed 2023-03-31 18:02
Tx date 2022-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$2,591
+366 vol
$7.08 each
Filed 2026-04-02 09:45
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$145,642
+10,100 vol
$14.42 each 		651,219
Filed 2026-04-02 09:44
Tx date 2026-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-20,201 vol 		641,119
Filed 2026-04-02 09:42
Tx date 2025-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$-88,865.50
-7,970 vol
$11.15 each 		658,861
Filed 2026-04-02 09:41
Tx date 2025-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-15,940 vol 		666,831
Filed 2026-04-02 09:34
Tx date 2023-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-31,862 vol 		656,069
Filed 2025-04-04 16:27
Tx date 2025-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$88,865
+7,970 vol
$11.15 each
Filed 2025-04-04 16:25
Tx date 2025-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+15,940 vol
Filed 2026-03-26 16:15
Tx date 2026-03-24 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+10,844 vol 		18,054
Filed 2026-03-26 16:14
Tx date 2026-03-01 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+6,333 vol 		7,210
Filed 2026-03-26 16:12
Tx date 2025-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
30 - Acquisition or disposition under a purchase/ownership plan 		$10,313
+877 vol
$11.76 each 		877
Filed 2026-03-26 16:08
Tx date 1996-01-04 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-26 16:07
Tx date 2025-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$28,548
+2,459 vol
$11.61 each 		741,002
Filed 2026-03-26 15:58
Tx date 2016-12-12 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$-2,400,000
-300,000 vol
$8.00 each 		657,500
Filed 2026-03-26 15:52
Tx date 2002-03-27 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aquiam Partners Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
+500,000 vol 		500,000
Filed 2026-03-26 15:48
Tx date 1996-01-04 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aquiam Partners Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-12-12 17:34
Tx date 2016-12-12 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately 		$-2,400,000
-300,000 vol
$8.00 each
Filed 2025-04-04 16:27
Tx date 2025-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$88,865
+7,970 vol
$11.15 each 		1,038,543
Filed 2025-04-04 16:25
Tx date 2025-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+15,940 vol 		1,030,573
Filed 2025-04-04 16:22
Tx date 2025-03-18 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+13,582 vol 		1,014,633
Filed 2025-04-04 16:17
Tx date 2024-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$8,454
+951 vol
$8.89 each 		1,001,051
Filed 2025-04-04 16:15
Tx date 2024-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$20,937
+2,130 vol
$9.83 each 		1,000,100
Filed 2024-06-17 18:46
Tx date 2024-06-12 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-14,276.36
-1,522 vol
$9.38 each 		997,970
Filed 2024-06-17 18:41
Tx date 2024-06-12 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$11,338
+1,522 vol
$7.45 each 		335,867
Filed 2024-04-02 18:36
Tx date 2024-03-27 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+17,103 vol 		999,492
Filed 2024-04-02 18:35
Tx date 2024-03-19 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$79,305
+9,330 vol
$8.50 each 		982,389
Filed 2024-04-02 18:34
Tx date 2024-03-19 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-18,661 vol 		973,059
Filed 2024-04-02 18:28
Tx date 2023-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$8,974
+1,164 vol
$7.71 each 		991,720
Filed 2024-04-02 18:27
Tx date 2023-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$20,343
+2,625 vol
$7.75 each 		990,556
Filed 2023-04-05 17:55
Tx date 2023-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+19,147 vol 		987,931
Filed 2023-03-31 18:02
Tx date 2022-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$2,591
+366 vol
$7.08 each 		968,784
Filed 2023-03-31 17:59
Tx date 2022-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$16,757
+2,074 vol
$8.08 each 		968,418
Filed 2022-04-04 11:25
Tx date 2022-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$138,004
+15,182 vol
$9.09 each 		966,344
Filed 2022-03-24 15:03
Tx date 2021-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$11,688
+1,516 vol
$7.71 each 		951,162
Filed 2021-03-24 17:28
Tx date 2021-03-19 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$131,998
+18,082 vol
$7.30 each 		949,646
Filed 2021-03-24 17:26
Tx date 2020-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,357
+1,063 vol
$5.04 each 		931,564
Filed 2020-04-02 12:58
Tx date 2020-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$113,751
+31,510 vol
$3.61 each 		930,501
Filed 2020-03-31 18:26
Tx date 2020-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,400
+4,000 vol
$3.60 each 		898,991
Filed 2020-03-31 18:21
Tx date 2020-03-31 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$15,495
+2,114 vol
$7.33 each 		894,991
Filed 2019-03-27
Tx date 2018-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$15,000
+1,574 vol
$9.53 each 		892,877
Filed 2019-03-24
Tx date 2019-03-19 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$98,113
+11,936 vol
$8.22 each 		334,345
Filed 2018-12-21
Tx date 2018-12-21 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
10 - Acquisition or disposition in the public market 		$-64,545
-8,275 vol
$7.80 each 		322,509
Filed 2018-12-21
Tx date 2018-12-21 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$37,268
+8,375 vol
$4.45 each 		330,784
Filed 2018-12-21
Tx date 2018-12-21 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
10 - Acquisition or disposition in the public market 		$-781.00
-100 vol
$7.81 each 		322,409
Filed 2018-09-12
Tx date 2018-09-12 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-345,600
-36,000 vol
$9.60 each 		891,303
Filed 2018-09-12
Tx date 2018-09-10 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,825
-500 vol
$9.65 each 		968,155
Filed 2018-09-12
Tx date 2018-09-07 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-169,035
-17,700 vol
$9.55 each 		968,655
Filed 2018-09-12
Tx date 2018-09-10 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-392,179.20
-40,852 vol
$9.60 each 		927,303
Filed 2018-03-27
Tx date 2017-12-31 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$13,995
+1,562 vol
$8.96 each 		986,355
Filed 2018-01-12
Tx date 2018-01-08 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$93,456
+9,735 vol
$9.60 each 		322,409
Filed 2017-12-23
Tx date 2017-12-18 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$96,725
+9,800 vol
$9.87 each 		984,793
Filed 2017-12-23
Tx date 2017-12-18 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$8,918
+9,800 vol
$0.91 each 		312,674
Filed 2017-07-04
Tx date 2017-07-04 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$139,944
+17,493 vol
$8.00 each 		974,993
Filed 2017-03-18
Tx date 2017-03-15 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$85,480
+11,630 vol
$7.35 each 		302,874
Filed 2016-12-12
Tx date 2016-12-02 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$33,000
+300,000 vol
$0.11 each 		591,244
Filed 2016-12-12
Tx date 2016-12-12 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately 		$-2,400,000
-300,000 vol
$8.00 each 		291,244
Filed 2016-02-17
Tx date 2016-02-12 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$53,053
+8,557 vol
$6.20 each 		291,244
Filed 2016-01-21
Tx date 2016-01-13 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$33,000
+300,000 vol
$0.11 each
Filed 2016-01-21
Tx date 2016-01-13 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$-33,000
-300,000 vol
$0.11 each 		282,687
Filed 2016-01-20
Tx date 2016-01-13 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$33,000
+300,000 vol
$0.11 each 		957,500
Filed 2016-01-18
Tx date 2016-01-13 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$33,000
+300,000 vol
$0.11 each 		882,687
Filed 2015-08-31
Tx date 2015-08-24 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$3,300
+30,000 vol
$0.11 each 		657,500
Filed 2015-08-31
Tx date 2015-08-24 		$RX
BioSyent Inc. 		Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$3,300
+30,000 vol
$0.11 each 		582,687